Incidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in China
about
The Mental Health of People Living with HIV in China, 1998-2014: A Systematic ReviewThe influence of HLA on HIV-associated neurocognitive impairment in Anhui, ChinaFunctional polymorphisms in dopamine-related genes: effect on neurocognitive functioning in HIV+ adults.Neuropsychological test performance among healthy persons in northern India: development of normative data.Cognitive Decline in Relation to Psychological Wellbeing and HIV Disease- and Treatment Characteristics in HIV-Infected Patients on cART: A One-Year Follow-Up Study.Neurobehavioral effects in HIV-positive individuals receiving highly active antiretroviral therapy (HAART) in Gaborone, BotswanaNormative data and validation of a regression based summary score for assessing meaningful neuropsychological change.APOE epsilon4 and MBL-2 O/O genotypes are associated with neurocognitive impairment in HIV-infected plasma donors.Subcortical brain atrophy persists even in HAART-regulated HIV disease.Neurocognitive change in the era of HIV combination antiretroviral therapy: the longitudinal CHARTER study.Regional areas and widths of the midsagittal corpus callosum among HIV-infected patients on stable antiretroviral therapies.Controversies in HIV-associated neurocognitive disordersPersistence of HIV-associated cognitive impairment, inflammation, and neuronal injury in era of highly active antiretroviral treatmentCerebrospinal fluid (CSF) CD8+ T-cells that express interferon-gamma contribute to HIV associated neurocognitive disorders (HAND)Quantifying cognition at the bedside: a novel approach combining cognitive symptoms and signs in HIV.The effects of antiretroviral treatment initiation on cognition in HIV-infected individuals with advanced disease in Pune, India.Does Older Age Confer an Increased Risk of Incident Neurocognitive Disorders Among Persons Living with HIV Disease?Genome-wide association study of neurocognitive impairment and dementia in HIV-infected adultsCognitive change trajectories in virally suppressed HIV-infected individuals indicate high prevalence of disease activitySubtype associations with HIV-associated neurocognitive disorder in ChinaAssessment, diagnosis, and treatment of HIV-associated neurocognitive disorder: a consensus report of the mind exchange programValidity of cognitive screens for HIV-associated neurocognitive disorder: a systematic review and an informed screen selection guideDiagnosing symptomatic HIV-associated neurocognitive disorders: self-report versus performance-based assessment of everyday functioning.Absence of neurocognitive impairment in a large Chinese sample of HCV-infected injection drug users receiving methadone treatment.Neuropsychological performance in mainland china: the effect of urban/rural residence and self-reported daily academic skill use.Adding a brief self-report cognitive tool to the IHDS improves effectiveness of identifying patients with HIV-associated dementia in South Africa.Monitoring HIV-Associated Neurocognitive Disorder Using Screenings: a Critical Review Including Guidelines for Clinical and Research Use.The nature and consequences of cognitive deficits among tobacco smokers with HIV: a comparison to tobacco smokers without HIV.HIV-Associated Neurocognitive Disorders: A Global Perspective.
P2860
Q26747659-75682BE3-189D-4085-A1BF-09BC5F627ED7Q28729004-C2C779F0-1E51-41F2-9930-AD692E777B72Q30416710-4A4FD85C-B285-427F-AFF7-523DEE98E232Q30912122-1CAC5387-D468-4C9D-90FD-E41F98DDF361Q33650273-1B3D4F12-6F0D-4ADB-A9DD-F8C45430A2D9Q33834140-37E2DCFE-C47C-4699-B496-2ED4490C6C7CQ33842454-BD098088-46D0-4B62-A390-0FEB527FC92BQ34714286-4F9BFBDF-E6E1-4438-ACAA-6684E1A18B17Q34862412-57DD6F30-EE87-4D9E-B43C-685C73D782A4Q35003408-C8A80CE5-77DA-44DF-8C34-3985F12CD2C8Q35023780-C7201EDA-4701-489C-B1FB-B9A098B53A99Q35037015-18230053-F60B-406B-82C3-DDB1B973BC60Q35078313-4A439492-51AB-41BC-85F3-9DE9A3D27AF0Q35125862-7CA70ABE-2CC0-4989-8F7D-C9C7A1E7A13EQ35840202-4885730D-4039-41B8-889D-8E2CF148DCA2Q35883236-F4E9E42D-8A14-43AA-92C0-A954459FBD3FQ36060119-5799874B-5566-4B4E-BB13-12E038145833Q36162221-20F4FEF8-7E39-41C4-821D-1C943FC0E78AQ36298436-36124321-330B-4687-894B-C2AD6C025360Q36624481-83416592-1323-4FC8-B58C-0163C13A7A74Q36853897-EE6E58BD-5B5F-44A4-AB24-8EE48C0BA5E8Q37365305-3A248D69-514E-4575-92B7-845A043CE951Q37439362-8BB569DA-7B09-4709-B0CC-10F14A6230A6Q37652906-61439787-8C1B-4288-9329-51D5F4489EB8Q37658362-BDC70680-14AB-4CC7-B179-966439DAB4E4Q38658460-C34E8F6B-C404-43DB-8248-9E334A584689Q38747341-C5076632-A6BD-4A7B-A4BE-91CAC793B325Q40233429-3205E065-8F82-4C83-B660-4DD73E0A0C76Q46077781-52D03C98-E0D4-461D-BA06-4C2EE7444742
P2860
Incidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in China
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Incidence and nature of cognit ...... former plasma donors in China
@ast
Incidence and nature of cognit ...... former plasma donors in China
@en
type
label
Incidence and nature of cognit ...... former plasma donors in China
@ast
Incidence and nature of cognit ...... former plasma donors in China
@en
prefLabel
Incidence and nature of cognit ...... former plasma donors in China
@ast
Incidence and nature of cognit ...... former plasma donors in China
@en
P2093
P2860
P50
P1433
P1476
Incidence and nature of cognit ...... former plasma donors in China
@en
P2093
Christopher Ake
Donald R Franklin
HIV Neurobehavioral Research Center group
Ian S Abramson
Lucette A Cysique
Saurabh Gupta
P2860
P304
P356
10.1097/QAD.0B013E32833336C8
P407
P577
2010-04-01T00:00:00Z